Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6997)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2017 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lovecek M, Skalicky P, Chudacek J, Szkorupa M, Svebisova H, Lemstrova R, Ehrmann J, Melichar B, Yogeswara T, Klos D, Vrba R, Havlik R, Mohelnikova-Duchonova B. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature. World J Gastroenterol 2017; 23(35): 6420-6428 [PMID: 29085191 DOI: 10.3748/wjg.v23.i35.6420] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i35/6420.htm |
| Number | Citing Articles |
| 1 |
Martin Loveček, Pavel Skalický, Ondřej Urban, Jana Tesaříková, Martin Kliment, Róbert Psár, Hana Švébišová, Kateřina Urban, Beatrice Mohelníková-Duchoňová, Dušan Klos, Martin Stašek. Isolated Gastric Metastases of Pancreatic Ductal Adenocarcinoma following Radical Resection—Impact of Endosonography-Guided Fine Needle Aspiration Tract Seeding. Biomedicines 2022; 10(6): 1392 doi: 10.3390/biomedicines10061392
|
| 2 |
C.-S. Leonhardt, T. Stamm, T. Hank, G. Prager, O. Strobel. Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus. ESMO Open 2023; 8(6): 102067 doi: 10.1016/j.esmoop.2023.102067
|
| 3 |
Taro Mashiko, Akira Nakano, Yoshihito Masuoka, Seiichiro Yamamoto, Soji Ozawa, Toshio Nakagohri. Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01236-w
|
| 4 |
Kun Wang, Zhiqiang Hao, Xibo Fu, Wenxin Li, Ao Jiao, Xiangdong Hua. Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer. Molecular and Cellular Biochemistry 2022; 477(7): 1947 doi: 10.1007/s11010-022-04404-5
|
| 5 |
Tatsuma Sakaguchi, Roberto Valente, Kimitaka Tanaka, Sohei Satoi, Marco Del Chiaro. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. Pancreatology 2019; 19(5): 672 doi: 10.1016/j.pan.2019.05.466
|
| 6 |
Thomas Seufferlein, Julia Mayerle, Stefan Böck, Thomas Brunner, Thomas J. Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika Kestler, Marianne Sinn, Andrea Tannapfel, Ulrich Wedding, Waldemar Uhl. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL. Zeitschrift für Gastroenterologie 2022; 60(11): e812 doi: 10.1055/a-1856-7346
|
| 7 |
Koki Hayashi, Yoshihiro Ono, Manabu Takamatsu, Atsushi Oba, Hiromichi Ito, Takafumi Sato, Yosuke Inoue, Akio Saiura, Yu Takahashi. Prediction of Recurrence Pattern of Pancreatic Cancer Post-Pancreatic Surgery Using Histology-Based Supervised Machine Learning Algorithms: A Single-Center Retrospective Study. Annals of Surgical Oncology 2022; 29(7): 4624 doi: 10.1245/s10434-022-11471-x
|
| 8 |
Yoshiyuki Shibata, Kenichiro Uemura, Tatsuaki Sumiyoshi, Kenjiro Okada, Hiroyuki Otsuka, Masahiro Serikawa, Yasutaka Ishii, Yoshiaki Murakami, Koji Arihiro, Shinya Takahashi. Surgical resection for liver recurrence after curative resection of pancreatic ductal adenocarcinoma. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-03009-w
|
| 9 |
Sergio Pedrazzoli. Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor. Journal of Clinical Medicine 2023; 12(20): 6461 doi: 10.3390/jcm12206461
|
| 10 |
Sami A. Safi, Alexander Rehders, Lena Haeberle, Stephen Fung, Nadja Lehwald, Irene Esposito, Farid Ziayee, Andreas Krieg, Wolfram T. Knoefel, Georg Fluegen. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?. Surgery 2021; 170(6): 1807 doi: 10.1016/j.surg.2021.06.045
|
| 11 |
Feifei Shen, Chuan Liu, Weiguo Zhang, Sijia He, Fan Wang, Jingjue Wang, Qi Li, Fei Zhou. Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.964115
|
| 12 |
Hiroshi Kurahara, Kosei Maemura, Yuko Mataki, Kiyonori Tanoue, Satoshi Iino, Yota Kawasaki, Tetsuya Idichi, Takaaki Arigami, Shinichiro Mori, Yoshiaki Shinden, Michiyo Higashi, Shinichi Ueno, Hiroyuki Shinchi, Shoji Natsugoe. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer. Pancreatology 2020; 20(1): 89 doi: 10.1016/j.pan.2019.11.015
|
| 13 |
Ryota Matsuki, Masanori Sugiyama, Hidefumi Takei, Haruhiko Kondo, Masachika Fujiwara, Junji Shibahara, Junji Furuse. Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report. Surgical Case Reports 2018; 4(1) doi: 10.1186/s40792-018-0435-2
|
| 14 |
E. Martin-Perez, J. E. Domínguez-Muñoz, F. Botella-Romero, L. Cerezo, F. Matute Teresa, T. Serrano, R. Vera. Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer. Clinical and Translational Oncology 2020; 22(11): 1963 doi: 10.1007/s12094-020-02350-6
|
| 15 |
Jennifer A. Yonkus, Roberto Alva-Ruiz, Amro M. Abdelrahman, Jennifer L. Leiting, Amber R. Schneider, Travis E. Grotz, Sean P. Cleary, Rory L. Smoot, David M. Nagorney, Michael L. Kendrick, Benjamin R. Kipp, Mark J. Truty. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial. Journal of the American College of Surgeons 2021; 233(1): 73 doi: 10.1016/j.jamcollsurg.2021.05.009
|
| 16 |
Yuki Homma, Itaru Endo, Ryusei Matsuyama, Masayuki Sho, Shugo Mizuno, Yasuji Seyama, Satoshi Hirano, Takashi Aono, Chie Kitami, Yoshifumi Morita, Yutaka Takeda, Kazuhiro Yoshida, Masaji Tani, Takashi Kaiho, Yuzo Yamamoto, Hideki Aoki, Masao Ogawa, Takefumi Niguma, Yuko Mataki, Hiroshi Kawasaki, Hideo Baba, Hiroshi Yokomizo, Toshiki Rikiyama, Hiroki Yamaue, Masakazu Yamamoto. Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(5): 552 doi: 10.1002/jhbp.1127
|
| 17 |
Xiangrong Xu, Danyang Hou, Yujie Wang, Jing Zhang, Yu Hei, Bobo Wang, Shuyue Tian, Yunqing Zhang, Fenghui Wang. Knockdown of NF-κB activating protein promotes pancreatic cancer growth and metastasis through mTOR signaling pathway. Molecular Biology Reports 2023; 50(9): 7501 doi: 10.1007/s11033-023-08665-1
|
| 18 |
Vincent P. Groot, Lois A. Daamen, Jin He, Christopher L. Wolfgang, I. Quintus Molenaar. Textbook of Pancreatic Cancer. 2021; : 1153 doi: 10.1007/978-3-030-53786-9_74
|
| 19 |
Carole Vitellius, Océane Griveaux, Benjamin Morvant, Estelle Pedrono, Aurélien Venara, Olivier Ingster, Nathalie Baize, Eloise Dincuff, Marie-Christine Rousselet, Philippe Guardiola, François-Xavier Caroli-Bosc. Impact of Driver Mutations on the Evolution of Isolated Metachronous Lung Metastasis of Pancreatic Ductal adenocarcinoma. Molecular Diagnosis & Therapy 2020; 24(4): 443 doi: 10.1007/s40291-020-00472-9
|
| 20 |
Xiaodong Xu, Yan Yu, Ke Zong, Pengwei Lv, Yuantin Gu. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1470-y
|
| 21 |
Orimisan Samuel Adekolujo, Ahsan Wahab, Maxwell Oluwole Akanbi, Tolutope Oyasiji, Borys Hrinczenko, Olatunji Boladale Alese. Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2198479
|
| 22 |
Yixuan Ma, Sina Sender, Anett Sekora, Weibo Kong, Peter Bauer, Najim Ameziane, Susann Krake, Mandy Radefeldt, Ruslan Al-Ali, Frank Ulrich Weiss, Markus M. Lerch, Alisha Parveen, Dietmar Zechner, Christian Junghanss, Hugo Murua Escobar. Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines. International Journal of Molecular Sciences 2022; 23(8): 4409 doi: 10.3390/ijms23084409
|
| 23 |
Takanori Konishi, Shigetsugu Takano, Tsukasa Takayashiki, Satoshi Kuboki, Daisuke Suzuki, Nozomu Sakai, Isamu Hosokawa, Takashi Mishima, Hitoe Nishino, Shinichiro Nakada, Masayuki Ohtsuka. Clinical benefits of pulmonary resection for lung metastases from pancreatic cancer. Langenbeck's Archives of Surgery 2023; 409(1) doi: 10.1007/s00423-023-03198-4
|
| 24 |
S. A. Safi, N. Lehwald-Tywuschik, A. Rehders, G. Fluegen, L. Haeberle, V. Keitel, W. T. Knoefel. Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01082-w
|
| 25 |
Orsi Giulia, Bandiera Alessandro, Carretta Angelo, Migliori Paolo, Chavez Rosa, Macchini Marina, Peretti Umberto, Carconi Catia, Veronesi Giulia, Falconi Massimo, Reni Michele. Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease. Seminars in Oncology 2024; doi: 10.1053/j.seminoncol.2024.04.001
|
| 26 |
Vincent P. Groot, Alex B. Blair, Georgios Gemenetzis, Ding Ding, Richard A. Burkhart, A. Floortje van Oosten, I. Quintus Molenaar, John L. Cameron, Matthew J. Weiss, Stephen C. Yang, Christopher L. Wolfgang, Jin He. Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival. HPB 2019; 21(8): 998 doi: 10.1016/j.hpb.2018.12.002
|
| 27 |
Isabell Luisa Wahler, Alexander Damanakis, Nils Große Hokamp, Christiane Bruns, Thomas Schmidt. Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma. Cancers 2023; 15(24): 5881 doi: 10.3390/cancers15245881
|
| 28 |
Yixuan Ma, Sina Sender, Anett Sekora, Weibo Kong, Peter Bauer, Najim Ameziane, Ruslan Al-Ali, Susann Krake, Mandy Radefeldt, Frank Ulrich Weiss, Markus M. Lerch, Alisha Parveen, Dietmar Zechner, Christian Junghanss, Hugo Murua Escobar. The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines. International Journal of Molecular Sciences 2022; 23(8): 4295 doi: 10.3390/ijms23084295
|
| 29 |
Yudai Miyashita, Naoko Ose, Jiro Okami, Koji Takami, Yasushi Sakamaki, Naoki Ikeda, Masanobu Hayakawa, Masahiko Higashiyama, Ken Kodama, Yoshiyuki Susaki, Yasunobu Funakoshi, Jun Maeda, Yasushi Shintani. Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer. Surgery Today 2023; 53(11): 1236 doi: 10.1007/s00595-023-02701-0
|
| 30 |
Hui Wu, Anshu Li, Qichang Zheng, Jingyang Gu, Wei Zhou. LncRNA LZTS1-AS1 induces proliferation, metastasis and inhibits autophagy of pancreatic cancer cells through the miR-532 /TWIST1 signaling pathway. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02979-7
|
| 31 |
Hüseyin Akkaya, Selim Özdemir, Okan Dilek, Ali Can Topaloglu, Ahmet Ziya Bayhan, Zeynel Abidin Taş, Cihan Gökler, Bozkurt Gülek. Evaluation of the performance of and interobserver agreement on postoperative baseline CT findings in the identification of locoregional recurrence in patients with pancreatic ductal adenocarcinoma. Abdominal Radiology 2023; 48(10): 3135 doi: 10.1007/s00261-023-04012-x
|
| 32 |
Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. Journal of Clinical Medicine 2019; 8(9): 1402 doi: 10.3390/jcm8091402
|
| 33 |
Viktor Hlavac, Beatrice Mohelnikova-Duchonova, Martin Lovecek, Jiri Ehrmann, Veronika Brynychova, Katerina Kolarova, Pavel Soucek. Targeted Sequencing of Pancreatic Adenocarcinomas from Patients with Metachronous Pulmonary Metastases. Genes 2020; 11(12): 1391 doi: 10.3390/genes11121391
|
| 34 |
Travis E. Grotz, Jennifer A. Yonkus, Cornelius A. Thiels, Susanne G. Warner, Robert R. McWilliams, Amit Mahipal, Tanios S. Bekaii-Saab, Sean P. Cleary, Michael L. Kendrick, Mark J. Truty. Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study. Annals of Surgical Oncology 2023; 30(1): 395 doi: 10.1245/s10434-022-12328-z
|
| 35 |
Tatsuaki Sumiyoshi, Kenichiro Uemura, Ryuta Shintakuya, Kenjiro Okada, Hiroyuki Otsuka, Kenta Baba, Masahiro Serikawa, Yasutaka Ishii, Tomofumi Tsuboi, Koji Arihiro, Yoshiaki Murakami, Jyunji Murashita, Shinya Takahashi. Prognostic factor in patient with recurrent pancreatic adenocarcinoma. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-03073-2
|
| 36 |
Masafumi Imamura, Minoru Nagayama, Daisuke Kyuno, Shigenori Ota, Takeshi Murakami, Akina Kimura, Hiroshi Yamaguchi, Toru Kato, Yasutoshi Kimura, Ichiro Takemasa. Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer. Cancers 2021; 13(10): 2285 doi: 10.3390/cancers13102285
|
| 37 |
Thilo Hackert, Markus W. Büchler. Response to the Comment on “Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer”. Annals of Surgery 2021; 274(6): e899 doi: 10.1097/SLA.0000000000004872
|
| 38 |
Tomas Zemanek, Bohuslav Melichar, Martin Lovecek, Pavel Soucek, Beatrice Mohelnikova-Duchonova. Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma. Pharmacogenomics 2019; 20(2): 113 doi: 10.2217/pgs-2018-0073
|
| 39 |
M Tanaka, A L Mihaljevic, P Probst, M Heckler, U Klaiber, U Heger, M W Büchler, T Hackert. Meta-analysis of recurrence pattern after resection for pancreatic cancer. British Journal of Surgery 2019; 106(12): 1590 doi: 10.1002/bjs.11295
|
| 40 |
Hiroyuki Otsuka, Kenichiro Uemura, Naru Kondo, Tatsuaki Sumiyoshi, Naoya Nakagawa, Kenjiro Okada, Shingo Seo, Yoshiaki Murakami, Shinya Takahashi. Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma. Pancreatology 2020; 20(7): 1472 doi: 10.1016/j.pan.2020.08.019
|
| 41 |
Yu Asakura, Hirochika Toyama, Jun Ishida, Sadaki Asari, Sachio Terai, Sachiyo Shirakawa, Hironori Yamashita, Takashi Shimizu, Yuta Ogura, Ippei Matsumoto, Hidetoshi Gon, Daisuke Tsugawa, Shohei Komatsu, Kaori Kuramitsu, Hiroaki Yanagimoto, Masahiro Kido, Tetsuo Ajiki, Takumi Fukumoto. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma. Asian Journal of Surgery 2023; 46(1): 207 doi: 10.1016/j.asjsur.2022.03.043
|
| 42 |
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochemical and Biophysical Research Communications 2018; 501(1): 313 doi: 10.1016/j.bbrc.2018.05.024
|